3-(5-Bromo-1H-indol-3-yl)-1-diazonioprop-1-en-2-olate | 919295-73-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(5-Bromo-1H-indol-3-yl)-1-diazonioprop-1-en-2-olate
• 英文别名: 1-(5-bromo-1H-indol-3-yl)-3-diazopropan-2-one
• CAS: 919295-73-1
• 化学式: C₁₁H₈BrN₃O
• 分子量: 278.108
• InChiKey: VZFTXFVBVKWCQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  34.9
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(5-Bromo-1H-indol-3-yl)-1-diazonioprop-1-en-2-olate 、 potassium thioacetate 在 盐酸 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 以59%的产率得到S-(3-(5-Bromo-1H-indol-3-yl)-2-oxopropyl) ethanethioate
  参考文献：
  名称：

  Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors

  摘要：

  New classes of antibiotics are urgently needed to counter increasing levels of pathogen resistance. Peptide deformylase (PDF) was originally selected as a specific bacterial target, but a human homologue, the inhibition of which causes cell death, was recently discovered. We developed a dual-screening strategy for selecting highly effective compounds with low inhibition effect against human PDF. We selected a new scaffold in vitro that discriminated between human and bacterial PDFs. Analyses of structure-activity relationships identified potent antibiotics such as 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide (6b) with the same mode of action in vivo as previously identified PDF inhibitors but without the apoptotic effects of these inhibitors in human cells.

  DOI：

  10.1021/jm060910c
• 作为产物：
  描述：

  重氮甲烷 、 5-溴吲哚-3-乙酸 在 氯化亚砜 作用下， 以 二氯甲烷 、 乙醚 为溶剂， 反应 7.0h， 以95%的产率得到3-(5-Bromo-1H-indol-3-yl)-1-diazonioprop-1-en-2-olate
  参考文献：
  名称：

  Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors

  摘要：

  New classes of antibiotics are urgently needed to counter increasing levels of pathogen resistance. Peptide deformylase (PDF) was originally selected as a specific bacterial target, but a human homologue, the inhibition of which causes cell death, was recently discovered. We developed a dual-screening strategy for selecting highly effective compounds with low inhibition effect against human PDF. We selected a new scaffold in vitro that discriminated between human and bacterial PDFs. Analyses of structure-activity relationships identified potent antibiotics such as 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide (6b) with the same mode of action in vivo as previously identified PDF inhibitors but without the apoptotic effects of these inhibitors in human cells.

  DOI：

  10.1021/jm060910c

文献信息

• Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors
  作者：Adrien Boularot、Carmela Giglione、Sylvain Petit、Yann Duroc、Rodolphe Alves de Sousa、Valéry Larue、Thierry Cresteil、Frédéric Dardel、Isabelle Artaud、Thierry Meinnel

  DOI：10.1021/jm060910c

  日期：2007.1.1

  New classes of antibiotics are urgently needed to counter increasing levels of pathogen resistance. Peptide deformylase (PDF) was originally selected as a specific bacterial target, but a human homologue, the inhibition of which causes cell death, was recently discovered. We developed a dual-screening strategy for selecting highly effective compounds with low inhibition effect against human PDF. We selected a new scaffold in vitro that discriminated between human and bacterial PDFs. Analyses of structure-activity relationships identified potent antibiotics such as 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide (6b) with the same mode of action in vivo as previously identified PDF inhibitors but without the apoptotic effects of these inhibitors in human cells.